Stereotaxis, a company focused on innovative robotic technologies for the treatment of cardiac arrhythmias, introduced the Stereotaxis Genesis RMN, a next- generation robotic platform and significant advancement in robotic magnetic navigation technology.
“I am excited and pleased to introduce Stereotaxis Genesis, the future of robotic electrophysiology,” said David Fischel, Chairman and CEO of Stereotaxis. “Genesis is a new beginning for Stereotaxis. It is the tangible reflection of Stereotaxis’ commitment to innovation that improves patient care, enhances the physician experience, and enables broad availability of robotic electrophysiology.”
The Stereotaxis Genesis RMN system provides the established benefits and reliability of robotic magnetic navigation in a highly innovative architecture that is faster, smaller, lighter and more flexible. Since the original launch of the Niobe I system in 2003, improvements in Stereotaxis’ robotic system have remained iterative. Genesis RMN utilizes novel smaller magnets that rotate along their center of mass and are held by flexible robotic arms. This mechanism allows for instantaneous responsiveness to physician control and the flexibility to accommodate an increased range of motion. The Genesis RMN system’s significant reduction in size will improve the patient experience and provides physicians and nurses greater access to the patient during the procedure. The system represents a platform able to accommodate significant innovation in the future.
Stereotaxis Genesis RMN is being launched concurrently with Stereotaxis Imaging Model S as an integrated complete solution for a robotic interventional operating room. Stereotaxis Imaging Model S is a single-plane full-power x-ray system designed to be specifically available with the Genesis RMN system. It includes the c-arm, powered table, motorized boom, and large high-definition monitors. Developed in collaboration with Omega Medical Imaging, Stereotaxis Imaging incorporates modern fluoroscopy technology designed to support high quality imaging while minimizing radiation exposure for patients and physicians. The combination of Genesis RMN with Stereotaxis Imaging in a tightly integrated fashion significantly reduces the cost of acquisition, the ongoing cost of ownership, and the complexity of installation of a robotic electrophysiology practice.
“Dr. Natale and I had the opportunity to observe the Genesis and Stereotaxis Imaging systems in person,” said Dr. J. David Burkhardt, cardiac electrophysiologist, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center. “I consider this a significant and impressive leap forward, and am excited to see the positive impact of this innovation on patient care, procedure efficiency and the overall experience in the electrophysiology lab.”
“We are enthusiastic about the reinvigorated robotic innovation by Stereotaxis and are excited to see how this technology advances the field of electrophysiology,” added Dr. Andrea Natale, cardiac electrophysiologist and Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center.